FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Glickman Mark A 2. Date of Event Requiring Statement (Month/Day/Year) 07/28/2008 3. Issuer Name and Ticker or Trading Symbol OSCIENT PHARMACEUTICALS CORP [OSCI] (Last) (First) (Middle) 23 ORCHARD ROAD, SUITE 101 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) SVP, Sales & Marketing 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) SKILLMAN, NJ 08558 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock (1) 25,000 D   Common Stock (2) 1,157 D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to purchase)	  (3)	08/21/2017	Common Stock	50,000	$ 3.275	D	Â
Stock Option (right to purchase)	  (4)	02/24/2018	Common Stock	2,893	$ 2.16	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Glickman Mark A 23 ORCHARD ROAD SUITE 101 SKILLMAN, NJ 08558	Â	Â	  SVP, Sales & Marketing	Â

Signatures

Stanley F. Chalvire, Esq., Corporate Attorney - Power of Attorney		07/30/2008
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Restricted Shares issued under the Company's 2007 Employment Inducement Award Plan, which vest in four equal annual installments from August 22, 2007, the date of grant.
(2)	Restricted Shares issued under the Company's 2001 Incentive Plan, which vest in two equal annual installments from February 25, 2008, the date of grant.
(3)	Issued under the Company's 2007 Employment Inducement Award Plan and vest in four equal annual installments from August 22, 2007, the date of grant.
(4)	Issued under the Company's 2001 Incentive Plan and vest in equal quarterly installments over two years from February 25, 2008, the date of grant.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.